Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Structure-activity relationships of anthracyclines relative to effects on macromolecular syntheses.

× No keyword cloud information.

17 in total

1. Comparative effects of doxorubicin and 4'-epi-doxorubicin on nucleic acid metabolism and cytotoxicity in a human tumor cell line.

Authors: O Cantoni; P Sestili; F Cattabeni; C Geroni; F Giuliani
Journal: Cancer Chemother Pharmacol Date: 1990 Impact factor: 3.333

2. Effect of anthracycline antitumor antibiotics (adriamycin and nogalamycin) and cycloheximide on the biosynthesis and processing of major UsnRNAs.

Authors: R Ray; B K Chakraborty; K Ray; S Mukherji; J R Chowdhury; C K Panda
Journal: Mol Cell Biochem Date: 1996-09-06 Impact factor: 3.396

3. Induction of chromosomal aberrations by the anthracycline antitumor antibiotics N,N-dimethyldaunomycin and aclacinomycin A.

Authors: G Steinheider; J Westendorf; H Marquardt
Journal: Experientia Date: 1987-05-15

4. Plasma kinetics of aclacinomycin A and its major metabolites in man.

Authors: M J Egorin; D Van Echo; B M Fox; M Whitacre; N R Bachur
Journal: Cancer Chemother Pharmacol Date: 1982 Impact factor: 3.333

5. Phase II trial of aclacinomycin A in acute leukemia and various solid tumors.

Authors: J Schütte; N Niederle; S Seeber
Journal: J Cancer Res Clin Oncol Date: 1983 Impact factor: 4.553

6. Characterization of the cell growth inhibitory effects of a novel DNA-intercalating bipyridyl-thiourea-Pt(II) complex in cisplatin-sensitive and -resistant human ovarian cancer cells.

Authors: Gaetano Marverti; Alessio Ligabue; Monica Montanari; Davide Guerrieri; Matteo Cusumano; Maria Letizia Di Pietro; Leonarda Troiano; Elena Di Vono; Stefano Iotti; Giovanna Farruggia; Federica Wolf; Maria Giuseppina Monti; Chiara Frassineti
Journal: Invest New Drugs Date: 2009-10-16 Impact factor: 3.850

7. Nationwide randomized comparative study of daunorubicin and aclarubicin in combination with behenoyl cytosine arabinoside, 6-mercaptopurine, and prednisolone for previously untreated acute myeloid leukemia.

Authors: E Nagura; K Kimura; K Yamada; K Ohta; T Maekawa; F Takaku; H Uchino; T Masaoka; I Amaki; K Kawashima
Journal: Cancer Chemother Pharmacol Date: 1994 Impact factor: 3.333

8. Comparative murine metabolism and disposition of class II anthracycline antibiotics.

Authors: P Dodion; M J Egorin; C E Riggs; T A Ferraro; J M Tamburini; N R Bachur
Journal: Cancer Chemother Pharmacol Date: 1985 Impact factor: 3.333

9. Induction of erythroid differentiation by the anthracycline antitumor antibiotic pyrromycin.

Authors: G Steinheider; A Schaefer; J Westendorf; H Marquardt
Journal: Cell Biol Toxicol Date: 1988-03 Impact factor: 6.691

10. Comparative nuclear and cellular incorporation of daunorubicin, doxorubicin, carminomycin, marcellomycin, aclacinomycin A and AD 32 in daunorubicin-sensitive and -resistant Ehrlich ascites in vitro.

Authors: S Seeber; H Loth; S T Crooke
Journal: J Cancer Res Clin Oncol Date: 1980 Impact factor: 4.553